The decreased expression of SPARCL1 in UTUC clinical samples led us to investigate whether endogenous SPARCL1 plays a role in growth capability of UTUC cell lines. The gene discussed is SPARCL1; the disease is renal pelvis/ureter urothelial carcinoma.